“…Human CD300a is a transmembrane protein, with an immunoglobulin (Ig)V-like extracellular domain and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs), providing the receptor with an inhibitory capacity [ 1 , 2 ]. The relevance of the CD300a molecule in several pathological conditions has been highlighted by multiple studies [ 3 , 4 , 5 , 6 , 7 ]. Among others, CD300a has been related to bacterial, parasitic, and viral infections [ 4 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ].…”